USPTO serial 88335576
OCELIAN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAHONEY, PAULA M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OCELIAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SURESNES cedex, FR
SURESNES cedex, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III TEPPER & EYSTER, PLLC3724 BENSON DRIVERALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Apparatus and equipment for processing data and information, namely, apparatus for recording, transmission, processing and reproduction of sound, images or data; Apparatus and equipment for processing data and information, namely, computer hardware and downloadable software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Cloud servers ; Downloadable cloud-computing software for medical use ; downloadable computer programs for providing information on health and wellness, for entering new medical patient data into a database containing pre-recorded medical patient data, for managing and analyzing medical patient data within the database, for users to track their symptoms and record their treatments, for users to track physical activity and vital signs, for accessing and aggregating immunization data for use by health care providers, for tracking, recording and sharing healthcare information; downloadable computer software for analyzing, storing and monitoring of physiological data, including diagnostic, monitoring and warning tools; Personal digital assistants; downloadable data analysis software for use by health care providers to customize treatments based on patient profiles; Downloadable mobile software application for medical professionals and patients featuring information and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions; downloadable artificial intelligence software for healthcare in the field of medical diagnostics and medical monitors, downloadable artificial intelligence software for the analysis of patient data, medication information and drug interactions | ACTIVE | — |
| 010 | Medical analysis instruments to follow tumor imaging ; Medical diagnostic instruments to follow tumor imaging ; Medical device for detecting cancer; Medical device for treating cancer | ACTIVE | — |
| 035 | Collection, compilation and storage of data into computer databases; Updating, processing and maintenance of data in computer databases; Business advice and consultancy relating to financing business data analytics; Systemization of information into computer databases; Compilation of statistics; Business research and data analysis services in the field of genomics, medicine and life sciences; Business research and data analysis services in the field of cancer research, diagnostics, disease classification and personalized medicine; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals, and life sciences; all the aforesaid being provided in relation with the medical and pharmaceutical field | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable cloud-based software for accessing, storing and analyzing imaging data related to tumors and tumor progression | ACTIVE | — |
| 044 | Medical services; Providing medical testing services for diagnostic or treatment purposes and information in the field of personalized medicine; Advisory services relating to health; Pharmaceutical advice; Telemedicine services; Medical diagnostic testing, monitoring and reporting services; Medical reporting services, namely, compilation of medical reports; consultancy and information services relating to medical and pharmaceutical products; health consultancy and health counseling; health screening services in the fields of human physiology, activity, sleep, sleep apnea, cardiovascular health, dermatology, hearing, neurology, cancer, endocrinology, hormone and metabolic health; Medical diagnosis and treatment of cancer; medical evaluation of cancer, of the evolution of solid tumors during cancer treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioFarma
- Other trademarks owned by BIOFARMA
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OCELIAN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 11, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 10, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 5, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 4, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 1, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 1, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 30, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 30, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 30, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 1, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 1, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 1, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 3, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 1, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 1, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 1, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 2, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 2, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 2, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 18, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 10, 2019 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Sep 3, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 9, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 9, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 6, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 6, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 6, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 28, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 9, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 9, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 9, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 9, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 9, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 6, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2019 | ALIE | ASSIGNED TO LIE | — |
| Apr 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 15, 2019 | NWAP | NEW APPLICATION ENTERED | — |